Evidence map›Paper›PMID 34552649›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Qingre Yiqi Method along with Oral Hypoglycemic Drugs in Treating Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Li Jiang, Shidong Wang, Jinxi Zhao, Weijun Huang, Jiayue Li, Yonghua Xiao, Hua Zhang, Qiang Fu, Yu Chen, Tao Yang and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Li JiangGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0003-3827-2178
Shidong WangSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-6308-3208
Jinxi ZhaoSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-0593-2152
Weijun HuangKey Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-2704-4674
Jiayue LiSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Yonghua XiaoSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Hua ZhangSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Qiang FuSection II of Endocrinology & Nephropathy Department of Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Yu ChenGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Tao YangGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Esther Aijia ShenGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Guanxun SuGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Yaofu ZhangGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Zhuang LiGraduate School, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, China.
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the efficacy of the Qingre Yiqi method in the treatment of type 2 diabetes mellitus (T2DM) with meta-analysis.

methodThe randomized controlled trials (RCTs) of the Qingre Yiqi method in the treatment of T2DM in the PubMed, Medline, EMBase, Cochrane Library, Web of Science, Weipu Journal, China Knowledge Network (CNKI), and Wanfang database were conducted. Three reviewers independently conducted the screening, extracted the data, and assessed methodological quality. Data analysis was performed using Rev Man 5.3 software for statistical analysis.

resultsA total of 15 RCTs, including 1440 patients, were included. The results showed that compared with oral hypoglycemic drugs alone, the add-on treatment of the Qingre Yiqi method could significantly improve Chinese medicine syndrome (OR (95%CI) = 3.66 [2.47,5.42],

conclusionCompared with the standard treatment, the Qingre Yiqi method along with oral hypoglycemic drugs showed the more beneficial effects for T2DM on improving TCM syndromes and reducing the blood glucose and partial lipid parameter.

Identifiers

PMID34552649
PMCPMC8452389
OpenAlexW3201156728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.